CLSN Archives - Page 2 of 9 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: RGSE Review & More

Real Goods Solar, Inc. RGSE

We put RGSE on watch in yesterday morning’s premarket watchlist, and it turned out to be the number one gainer of the day for us.

The stock traded in a range from 1.78 up to 3.25, for an intraday gain of 83% on immense volume of more than 410X the monthly average. It marked the second time this week that we caught a huge PR which rocketed a previously stagnant stock into the stratosphere, after seeing the same thing with ECYT on Monday.

The company entered into an exclusive license agreement with The Dow Chemical Company for the POWERHOUSE™ solar shingles system, an innovative and aesthetically pleasing solar shingle system developed by Dow. (>>View PR)

We’ll continue to keep an eye on this play and watch for the establishment of higher highs and higher lows in coming sessions.

Constellation Brands, Inc. STZ – Options Idea

We’ve been waiting for a solid earnings beat gapper, which is typically the type of play we look for with regard to quick strike options ideas. STZ fits the mold today, after posting enhanced profits and outlook this morning.

The stock has been in a general uptrend for the whole of 2017, trading in an upward channel and is presently gapping up to new all-time highs. The range of calls we’ll be tracking after what could very well be a classic dip-and-rip formation are going to be the STZ 10/20 $210-220 Calls. That gives us a couple weeks to potentially see one or more significant swing trade opportunities.

Extended Watchlist:
ATOS, APVO, CDNA, COLL, INO, CLSN, ONVI, CERS

Blue Horseshoe Stocks: AAPL Options & More

Lumber Liquidators Holdings Inc. LL – Recap

Although LL did gap up a lot higher than expected to start the session, and larger gains would have been available at higher strike prices closer to the money, but most of our listed targets, the LL Weekly $27.50-29.50 Calls, still managed to see some solid intraday moves.

Those potential gains, including a double-bagger by the $28’s, were as follows:

$27.50 Calls – Range: 3.00-5.50 – Max Gain: 83%
$28 Calls – Range: 2.30-5.00 – Max Gain: 117%
$28.50 Calls – Range: 3.36-4.27 – Max Gain: 27%
$29 Calls – Range: 2.00-3.70 – Max Gain: 85%

Apple, Inc. AAPL

With AAPL breaking out to new all-time highs in the premarket this morning, after a strong earnings report was more than enough to assuage any concerns about lagging iPhone sales, we’re going to want to try to get in on the fun.

AAPL is gearing up to the point that it may also drive the DOW to the 22,000 level, causing a cascading effect that should make for an interesting week for traders across the board.

As for us, we’re going to be tracking the AAPL Weekly $155-162.50 Calls on the heels of this premarket mega-push that has thus far yielded a high of $160 on the nose.

Amarin Corp plc AMRN

We also want to take note of AMRN, which recently took a fair beating on the chart, and is showing clear signs of a reversal.

We also want to signal some calls in that options chain as well as watching the stock itself. The AMRN Weekly $4 Calls will be the options we put on our radar.

Extended Watchlist:
SRMX, STBV, RWLK, CLSN, CLDX, OGXI, MTW

Blue Horseshoe Stocks: PIXY Review & More

ShiftPixy, Inc. PIXY

As we were mentioning on Monday morning, we included PIXY in Friday’s report on its first ever trading day. Generally speaking we don’t tend to cast our lot in with brand new IPO’s, but a trusted source in our network gave us a heads-up on PIXY, and didn’t let us down.

We of course passed it along to our readers immediately in our premarket report on Friday, and the stock, after two trading days has made some really nice progress.

From the initial opening price of 6.30 we observed in PIXY, it went on to hit a high of 9.70 to kick off the short trading week on Monday. That marks a two-day swing of 54% for this newly-trading juggernaut. We’ll continue to be on the lookout for PIXY to keep recording higher base levels of support.

Opexa Therapeutics, Inc. OPXA

An honorable mention from Monday’s report is OPXA, especially considering that sessions just prior to a holiday break are typically low-key affairs.

The stock put up a solid intraday performance, running 35% from a low of a dollar up to 1.35, and pulling back into the close at 1.15. However, premarket activity this morning has seen the stock trade back to just below Monday’s high. This is one we’ll want to keep on our radar for the time being.

Aphria, Inc. APHQF

We’ve been familiar with APHQF for quite a time, but today will be the first occasion we’ve actually mentioned it in our reports.

Today, we wanted to point out that the company released two PR’s yesterday, the more significant of which was the announcement of a 1-year cannabis supply deal with a licensed Canadian medical provider which will bring upwards of $5M in revenue beginning midway through next year. We’ll provide links to both PR’s so you can check them out for yourself.

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer – 07/04

Tokyo Smoke to open Canadian flagship retail store on Queen Street West – 07/04

Extended Watchlist:
OTTV, CLSN, MSDI, MTBC, TOPS, GBR, FCEL

Blue Horseshoe Stocks: EKSO New Highs & More

Ekso Bionics Holdings, Inc. EKSO

What started as a nominal gainer that came off of our extended watchlist on Wednesday, EKSO rolled its 37% performance over into yesterday’s session, carrying on the multiday action. After a strong close at 1.81 on Thursday, we said we’d be interested in continuing to track EKSO as we head into week’s end, and it was a great idea.

The stock continued its ascent to a new high and reached 2.18. From Wednesday’s low of 1.40, it works out to a respectable two day swing of 56% Just as we mentioned yesterday, the stock closed strong again, and we’ll want to keep monitoring for higher highs and higher lows .

Valeant Pharmaceuticals, Inc. VRX – Options Idea

Valeant has been working its way down to an area of relative support recently, consolidating after a nice run off of its 52-week lows from April to May. This morning in the premarket, we’ve taken notice of the fact that VRX is gapping up considerably in the premarket.

We want to be waiting in the wings with an options idea to take advantage of the action following what could very well be an early dip-and-rip formation. We’ve called VRX and a ton of other such stocks in these positions, and done very well in the past.

We’ll be looking to the VRX Weekly $12 and 12.50 Calls* for possible swing trades today.

*We never include mentions of weekly options contracts on a Friday without explicitly warning our readers that trading weekly options at the end of the week is a hugely risky proposition that should not be attempted unless you are an expert trader!

Ampio Pharmaceuticals, Inc. AMPE

We want to point out a possible momentum play in AMPE. We’ve talked about this stock in the past, and as you can see from the included chart snapshot, it has been mounting a decent rebound effort off of a double bottom over the past few sessions.

We’re going to place AMPE on watch into next week, as a similar move to the one exhibited by the stock earlier this spring would mean considerable gains from this point.

Extended Watchlist:
HOS, MYO, CLSN, TAUG, GAHC, BTSC

Blue Horseshoe Stocks: NIHD Review & More

NII Holdings, Inc. NIHD

We initially tagged NIHD in our premarket report from last Thursday, and on that day we would observe a low of .5472 in the stock. It’s been stepping its way up, but this morning in premarket trading things have really kicked into high gear, with NIHD cracking through the dollar barrier.

As of this morning’s premarket high of 1.14, we’ve now witnessed an increase of 108% in NIHD over a span of just three trading sessions. In order for us to remain highly interested in this play, we’ll want to see it maintain support at or above its current 50DMA of .83 on any pullbacks that may occur.

Celsion Corp. CLSN

We called out CLSN in yesterday morning’s premarket report, and saw a modest yet respectable move out of that play as well. From a low of 3.85 the stock ran as high as 4.96, marking an intraday move of 29%

The stock was number four on the NASDAQ’s top gainer list for the day, and while it did end up tapering back to close near its daily lows, this morning it is gapping up again in the premarket. This surge of activity is primarily due to yesterday’s announcement of positive results in its ovarian cancer treatment trials.

We’ll definitely be keeping CLSN on our radars and watching for the continued establishment of higher lows off of our recently observed bottom.

Bitcoin Services, Inc. BTSC

BTSC was a part of the bitcoin watchlist we issued on May 25th in the midst of a bitcoin frenzy where the crypto-currency was soaring to new all-time highs.

The residual effect for plays like BTSC has been impressive, with with stocks PPS making a jump from our observed low of .0366 up to a new high of .164 yesterday, which represents a 348% rip which occurred over a period of just seven sessions.

Egalet Corp. EGLT

Not only is EGLT coming off of a bottom on the chart, but in the space of the past 36 hours, the company has made two major announcements.

Yesterday, it was made known that EGLT had “received a U.S. patent for its proprietary Guardian™ Technology tablet architecture used to create precise delivery of combination products with immediate-, delayed- and/or extended-release properties.” (>>View PR)

Today, the announcement was that “one of the largest payers in the United States will provide coverage of ARYMO® ER (morphine sulfate) extended-release tablets” (>>View PR)

Extended Watchlist:
KMI, GAHC, EBIO, GALT, IAG, BLDP, SBGL